Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: Comparison with dietary and lifestyle changes, and fibrate therapy [2]

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 3, 2004, Pages 878-880

  Manfredi, Roberto ^a   Calza, Leonardo ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BEZAFIBRATE; EFAVIRENZ; FATTY ACID ESTER; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; LOPINAVIR; NUCLEOSIDE ANALOG; OMEGA 3 FATTY ACID; OMEGA 3 FATTY ACID ESTER; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STATINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DYSLIPIDEMIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; KINESIOTHERAPY; LETTER; LIFESTYLE; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; ANTILIPEMIC AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FATTY ACIDS, OMEGA-3; FEMALE; HIV INFECTIONS; HUMANS; HYPERTRIGLYCERIDEMIA; LIFE STYLE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 3042737059     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200407010-00017     Document Type: Letter

References (18)

1. Calza L, Manfredi R, Chiodo F. Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART. Infection. 2002;30:26-31.
2. Green ML. Evaluation and management of dyslipidemia in patients with HIV infection. J Gen Intern Med. 2002;17:797-810.
3. Nolan D. Metabolic complications-associated with HIV protease inhibitor therapy. Drugs. 2003;63:2555-2574.
4. Calza L, Manfredi R, Farneti B, et al. Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy. Int J Antimicrob Agents. 2003;22:54-59.
5. Calza L, Manfredi R, Chiodo F. Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART. AIDS. 2003;17:851-859.
6. Dubé MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy. Clin Infect Dis. 2003;37:613-627.
7. Mauss S. HIV-associated and antiretroviral-induced hyperlipidaemia: an update. J HIV Ther. 2003;8:29-31.
8. Calza L, Manfredi R, Chiodo F. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother. 2003;53:10-14.
9. Manfredi R, Chiodo F. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate. J Infect. 2001;42:181-188.
10. Manfredi R, Calza L, Chiodo F. Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study involving over 550 patients. J Acquir Immune Defic Syndr. 2004;35:492-502.
11. Barrios A, Blanco F, Garcia-Beneyas T, et al. Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia. AIDS. 2002;16:2079-2081.
12. McCarty MF. Iatrogenic lipodystrophy in HIV patients: the need for very-low fat diets. Med Hypotheses. 2003;61:561-566.
13. Hellerstein MK, Wu K, McGrath M, et al. Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: relation to indices of cytokine production. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:258-270.
14. Pichard C, Sudre P, Karsegard V, et al. A randomized double-blind controlled study of 6 months of a nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. AIDS. 1998;12:53-63.
15. De Luis Roman DA, Bachiller P, Izaola O, et al. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial. Eur J Clin Nutr. 2001;55:1048-1052.
16. Sirtori CR, Crepaldi G, Manzato E, et al. One-year treatment with ethyl esters on n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL, without glycemic alterations. Atherosclerosis. 1998;137:419-427.
17. Xu A, Yin S, Wong L, et al. Adiponectin ameliorates dyslipidemia induced by the HIV protease inhibitor ritonavir in mice. Endocrinology. 2003;145:487-494.
18. Riddle TM, Fichtenbaum CJ, Hui DY. Leptin replacement therapy but not dietary polyun-saturated fatty acids alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice. J Acquir Immune Defic Syndr. 2003;33:564-570.